Literature DB >> 11384792

A multicenter two by two factorial trial of cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: design of a veterans affairs cooperative study (CSP #470).

P Guarino1, P Peduzzi, S T Donta, C C Engel, D J Clauw, D A Williams, J S Skinner, A Barkhuizen, L E Kazis, J R Feussner.   

Abstract

The Department of Veterans Affairs (VA) Cooperative Studies Program (CSP) Study #470 is a 2 x 2 factorial trial designed to evaluate the hypothesis that both cognitive behavioral therapy (CBT) and aerobic exercise will significantly improve physical function in participants with Gulf War veterans' illnesses (GWVI), and that adding CBT to aerobic exercise will provide further incremental benefit. One thousand three hundred fifty-six veterans will be randomized to one of four treatment arms: CBT plus aerobic exercise plus usual and customary care, aerobic exercise plus usual and customary care, CBT plus usual and customary care, or usual and customary care alone. The study duration is 2.5 years with 1.5 years of intake and 1 year of follow-up. The primary outcome measure is the proportion of veterans improved more than seven units on the physical component summary (PCS) scale of the Short Form Health Survey for Veterans (SF-36V) measured 12 months after randomization. This generic quality-of-life measure was chosen because there is no disease-specific measure for GWVI and the symptoms of GWVI span a wide range of physical manifestations that are related to the domains covered by the PCS scale. Sample size was determined to detect all six pairwise comparisons between the four treatment arms with 90% power and a Bonferroni adjustment for an overall type I error of 0.05 or 0.05/6 = 0.0083. CSP #470 was initiated in May 1999 in 18 VA and two Department of Defense medical centers. To date this represents the largest randomized trial designed to evaluate treatments for individuals with unexplained physical symptoms. This paper will focus on the rationale and unique features of the study design. Control Clin Trials 2001;22:310-332

Entities:  

Mesh:

Year:  2001        PMID: 11384792     DOI: 10.1016/s0197-2456(00)00133-1

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  7 in total

Review 1.  Resistance exercise training for fibromyalgia.

Authors:  Angela J Busch; Sandra C Webber; Rachel S Richards; Julia Bidonde; Candice L Schachter; Laurel A Schafer; Adrienne Danyliw; Anuradha Sawant; Vanina Dal Bello-Haas; Tamara Rader; Tom J Overend
Journal:  Cochrane Database Syst Rev       Date:  2013-12-20

Review 2.  Exercise therapy for chronic fatigue syndrome.

Authors:  Lillebeth Larun; Kjetil G Brurberg; Jan Odgaard-Jensen; Jonathan R Price
Journal:  Cochrane Database Syst Rev       Date:  2019-10-02

3.  Flexibility exercise training for adults with fibromyalgia.

Authors:  Soo Y Kim; Angela J Busch; Tom J Overend; Candice L Schachter; Ina van der Spuy; Catherine Boden; Suelen M Góes; Heather Ja Foulds; Julia Bidonde
Journal:  Cochrane Database Syst Rev       Date:  2019-09-02

4.  Telephone-Based versus In-Person Delivery of Cognitive Behavioral Treatment for Veterans with Chronic Multisymptom Illness: A Controlled, Randomized Trial.

Authors:  Lisa M McAndrew; Lauren M Greenberg; Donald S Ciccone; Drew A Helmer; Helena K Chandler
Journal:  Mil Behav Health       Date:  2017-07-11

5.  Mixed exercise training for adults with fibromyalgia.

Authors:  Julia Bidonde; Angela J Busch; Candice L Schachter; Sandra C Webber; Kristin E Musselman; Tom J Overend; Suelen M Góes; Vanina Dal Bello-Haas; Catherine Boden
Journal:  Cochrane Database Syst Rev       Date:  2019-05-24

Review 6.  Aerobic exercise training for adults with fibromyalgia.

Authors:  Julia Bidonde; Angela J Busch; Candice L Schachter; Tom J Overend; Soo Y Kim; Suelen M Góes; Catherine Boden; Heather Ja Foulds
Journal:  Cochrane Database Syst Rev       Date:  2017-06-21

Review 7.  Caring for medically unexplained physical symptoms after toxic environmental exposures: effects of contested causation.

Authors:  Charles C Engel; Joyce A Adkins; David N Cowan
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.